Despite decreased expression of Ccl2 mRNA in CD11b+ cells immunosorted from the tumor-bearing brains of OAT-1746-treated animals, the other cells in the tumor microenvironment could still be the source of the cytokine and augment Ccl2 plasma levels. This evidence concerns the gene CCL2 and neoplasm.